欢迎登录材料期刊网

材料期刊网

高级检索

冠状动脉支架置入术作为治疗心血管狭窄引起的冠心病的主要方法之一,得到了较为广泛、深入的研究.从材料的角度系统介绍了冠状动脉支架,包括支架基体材料、支架表面涂层材料和所载药物,并简要说明了药物涂层的组装工艺和冠状动脉支架的发展趋势.

参考文献

[1] Douglas J S .Role of adjunct pharmacologic therapy in the era of drug-eluting stents[J].Atherosclerosis(Suppl),2005,6(04):47.
[2] Dotter C T;Judkins M D .Transluminal treatment of arteriosclerotic obatruction:a new technique and a preliminary report of its application[J].Circulation,1964,30:654.
[3] Dotter C T .Transluminally placed coil spring endoarterial tube grafts,long term patency in canine politeal artery[J].Investigative Radiology,1969,4:329.
[4] Sigwart U;Puel J;Mirkovitch V et al.Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty[J].New England Journal of Medicine,1987,316:701.
[5] Poncin P;Proft J.Stent Tubing:Understanding the Desired Attributes[A].,2003:253.
[6] Tepe G;Schmehl J;Wendel HP;Schaffner S;Heller S;Gianotti M;Claussen CD;Duda SH .Reduced thrombogenicity of nitinol stents - In vitro evaluation of different surface modifications and coatings[J].Biomaterials,2006(4):643-650.
[7] Leng Y X;Chen J Y;Huang N et al.The biocompatibility of the tantalum and tantalum oxide films synthesized by pulse metal vacuum arc source deposition[J].Nuclear Instruments and Methods Physics Research,2006,242:30.
[8] Hagspiel KD;Leung DA;Nandalur KR;Angle JF;Dulai HS;Spinosa DJ;Matsumoto AH;Christopher JM;Ahmed H;Berr SS .Contrast-Enhanced MR Angiography at 1.5 T After Implantation of Platinum Stents: In Vitro and In Vivo Comparison with Conventional Stent Designs.[J].American Journal of Roentgenology,2005(1):288-294.
[9] Mario C D;Grube E;Nisanci Y et al.Moonlight:a controlled registry of an iridium oxide-coated stent with angiographic follow-up[J].International Journal of Cardiology,2004,95:329.
[10] Svedman C;Tillman C;Gustavsson CG;Moller H;Frennby B;Bruze M .Contact allergy to gold in patients with gold-plated intracoronary stents.[J].Contact dermatitis,2005(4):192-196.
[11] Stack T E;Califf R M;Phillips H P et al.Interventional cardiac catheterization at Duke medical center[J].American Journal of Cardiology,1998,62(zF):3.
[12] Tamai H;Igaki K;Kyo E et al.Initial and 6-month results of biodegradable poly-L-lactic coronary stents in humans[J].Circulation,2000,102:399.
[13] Alexis F;Venkatraman SS;Rath SK;Boey F .In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices[J].Journal of Controlled Release: Official Journal of the Controlled Release Society,2004(1):67-74.
[14] Frank A;Rath SK;Venkatraman SS .Controlled release from bioerodible polymers: effect of drug type and polymer composition[J].Journal of Controlled Release: Official Journal of the Controlled Release Society,2005(2):333-344.
[15] Erne P;Schier M;Resink T J .The road to bioabsorbable stents:reaching clinical reality?[J].Cardiovascular and Interventional Radiology,2006,29:11.
[16] Lincoff A M;Furst J G;Ellis S G et al.Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model[J].Journal of the American College of Cardiology,1997,29:808.
[17] Venkatraman S;Poh TL;Vinalia T;Mak KH;Boey F .Collapse pressures of biodegradable stents.[J].Biomaterials,2003(12):2105-2111.
[18] Venkatraman SS;Tan LP;Joso JFD;Boey YCF;Wang XT .Biodegradable stents with elastic memory[J].Biomaterials,2006(8):1573-1578.
[19] Di Mario C;Griffiths H;Goktekin O;Peeters N;Verbist J;Bosiers M;Deloose K;Heublein B;Rohde R;Kasese V;Ilsley C;Erbel R .Drug-eluting bioabsorbable magnesium stent.[J].Journal of interventional cardiology,2004(6):391-395.
[20] Sthulinger H .Magnesium in cardiovascular disease[J].J Clin Basic Cardiol,2002,5:55.
[21] Heublein B;Rohde R;Kaese V et al.Biocorrosion of magnesium alloys:A new principle in cardiovascular implant technology?[J].HEART,2003,89:651.
[22] Peeters P;Bosiers M;Verbist J;Deloose K;Heublein B .Preliminary results after application of absorbable metal stents in patients with critical limb ischemia.[J].Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists,2005(1):1-5.
[23] Eggebrecht H;Rodermann J;Hunold P et al.Novel magnetic esonance-compatible coronary stent the absorbable magnesium-alloy stent[J].Circulation,2005,112:303.
[24] Peuster M;Wohlsein P;Brugmann M et al.A novel approach to temporary stenting:Degradable cardiovascular stents produced from corrodible metal-results 6~18 months after implantation into New Zealand white rabbits[J].Heart,2001,86:563.
[25] Unverdorben M;Sippel B;Degenhardt R et al.Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings:the Tenax versus Nir Stent Study's longterm outcome[J].American Heart Journal,2003,145(04):17.
[26] Prunotto M;Isaia C;Gatti M A et al.Nitinol carbofilm coated stents for peripheral applications:Study in the porcine model[J].Journal of Materials Science:Materials in Medicine,2005,16:1231.
[27] Windecker S;Simon R;Lins M et al.Randomized comparison of a titanium-nitride-oxide-coated stent with a stain less steel stent for coronary revascularization-The TiNOX trial[J].Circulation,2005,111(20):2617.
[28] Kollum M;Farb A;Schreiber R;Terfera K;Arab A;Geist A;Haberstroh J;Wnendt S;Virmani R;Hehrlein C .Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.[J].Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions,2005(1):85-90.
[29] Mrowietz C;Franke RP;Seyfert UT;Park JW;Jung F .Haemocompatibility of polymer-coated stainless steel stents as compared to uncoated stents.[J].Clinical hemorheology and microcirculation,2005(2):89-103.
[30] Wang HJ;Lin ZX;Liu XM;Sheng SY;Wang JY .Heparin-loaded zein microsphere film and hemocompatibility[J].Journal of Controlled Release: Official Journal of the Controlled Release Society,2005(1/2):120-131.
[31] Chen MC;Liang HF;Chiu YL;Chang Y;Wei HJ;Sung HW .A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus[J].Journal of Controlled Release: Official Journal of the Controlled Release Society,2005(1):178-189.
[32] Finkelstein A;McClean D;Kar S et al.Local drug delivery via a coronary stent with programmable release pharmacokinetics[J].Circulation,2003,107(05):777.
[33] Valgimigli M;Malagutti P;Aoki J;Garcia Garcia HM;Rodriguez Granillo GA;van Mieghem CA;Ligthart JM;Ong AT;Sianos G;Regar E;Van Domburg RT;De Feyter P;de Jaegere P;Serruys PW .Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis.[J].Journal of the American College of Cardiology,2006(3):507-514.
[34] Kathuria Y P .The potential of biocompatible metallic stents and preventing restenosis[J].MATERIALS SCIENCE & ENGINEERING A-STRUCTURAL MATER,2006,417(40)
[35] Wieneke H;Dirsch O;Sawitowski T;Gu YL;Brauer H;Dahmen U;Fischer A;Wnendt S;Erbel R .Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits.[J].Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions,2003(3):399-407.
[36] Macionczyk F.;Thull R.;Gerold B. .Repassivating tantalum/tantalum oxide surface modification on stainless steel implants[J].Surface & Coatings Technology,2001(0):1084-1087.
[37] Trigwell S;De S;Sharma R et al.Structural evaluation of radially expandable cardiovascular stents encased in a polyurethane film[J].J Biomed Mater Res B:Appl Biomater,2006,76B:241.
[38] 倪中华;顾兴中;易红 等.[P].CN 200510040936.8,2005.
[39] 马晓意;李正阳;马丽娟 .[P].WO 2006058479-Al,2006.
[40] Witkowski A;Chmielak Z;Kruk M et al.Determinants of model of renarrowing after beta radiation for in stent restenosis[J].International Journal of Cardiology,2006,107:247.
[41] Cervinka P;Stasek J;Costa MA;Stursa J;Fiser M;Vodnansky P;Kocisova M;Veselka J;Pleskot M;Maly J .Intravascular ultrasound study of the effect of beta-emitting (55Co) stents on vascular remodeling and intimal proliferation.[J].Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions,2004(3):320-325.
[42] Ferko A;Paral J;Raupach J et al.Autologous vein stentgraft:feasibility study[J].Journal of Vascular and Interventional Radiology,2000,11(01):111.
[43] Stefanadis C;Toutouzas K;Tsiamis E et al.Stents covered by autologous venous grafts:feasibility and immediate and long-term results[J].American Heart Journal,2000,139(03):437.
[44] Nabel E G;Plautz G;Boyce F M et al.Recombinant gene expression in vivo within endothelial cells of the arterial wall[J].Science,1989,244(4910):1342.
[45] Kipshidze NN;Iversen P;Kim HS;Yiazdi H;Dangas G;Seaborn R;New G;Tio F;Waksman R;Mehran R;Tsapenko M;Stone GW;Roubin GS;Iyer S;Leon MB;Moses JW .Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model.[J].Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions,2004(4):518-527.
[46] Petrovie D;Peterlin B .Genetic markers of restenosis after coronary angioplasty and after stent implantation[J].Medical Science Monitor,2005,11(04):RA127.
上一张 下一张
上一张 下一张
计量
  • 下载量()
  • 访问量()
文章评分
  • 您的评分:
  • 1
    0%
  • 2
    0%
  • 3
    0%
  • 4
    0%
  • 5
    0%